Wave Life Sciences Cash Flow Statement
NASDAQ: WVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.46-0.01 (-0.29%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Wave Life Sciences free cash flow
In fiscal 2025, Wave Life Sciences generated -$187.5 million of operating cash flow and spent $718,000 on capital expenditures. That left free cash flow of -$188.2 million, a free-cash-flow margin of -440.5% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Wave Life Sciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -204.38M | -97.01M | -57.51M | -161.82M | -122.25M | -149.91M | -193.64M | -146.65M | -101.98M | -55.66M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 3.44M | 3.90M | 5.00M | 6.57M | 7.48M | 8.11M | 7.59M | 5.58M | 2.15M | 784.00K |
| Stock-Based Compensation | 24.97M | 13.14M | 9.79M | 17.19M | 16.41M | 14.30M | 19.51M | 15.60M | 12.14M | 6.85M |
| Change in Working Capital | -15.93M | -73.73M | 27.47M | 9.50M | 4.63M | 19.16M | -17.85M | 97.83M | -2.43M | 14.72M |
| Operating Cash Flow | -187.49M | -151.03M | -19.43M | -127.78M | -88.99M | -115.98M | -188.23M | -22.86M | -83.67M | -31.93M |
| Capital Expenditures | -718.00K | -938.00K | -1.11M | -1.36M | -560.00K | -1.34M | -3.92M | -9.94M | -18.89M | -5.57M |
| Investing Cash Flow | -718.00K | -938.00K | -1.11M | -1.25M | -560.00K | -1.34M | -3.92M | -9.94M | -18.89M | -5.56M |
| Financing Cash Flow | 488.24M | 253.89M | 132.53M | 67.19M | 55.83M | 154.54M | 164.40M | 65.09M | 94.37M | 29.12M |
| Net Change in Cash | 300.04M | 101.79M | 111.89M | -62.06M | -33.93M | 37.34M | -27.64M | 32.33M | -7.78M | -8.38M |
| Free Cash Flow | -188.21M | -151.96M | -20.55M | -129.14M | -89.55M | -117.32M | -192.15M | -32.80M | -102.56M | -37.49M |
This table shows 10 annual periods of Wave Life Sciences's cash flow statement, from FY 2025 back to FY 2016, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow WVE's reporting calendar. What is a cash flow statement?